MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 37 filers reported holding MILESTONE PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $5,576,000 | +14.7% | 851,291 | 0.0% | 0.11% | +31.7% |
| Q3 2021 | $4,861,000 | +3.8% | 851,291 | 0.0% | 0.08% | +17.1% |
| Q2 2021 | $4,682,000 | -5.0% | 851,291 | 0.0% | 0.07% | -4.1% |
| Q1 2021 | $4,929,000 | -13.6% | 851,291 | 0.0% | 0.07% | -9.9% |
| Q4 2020 | $5,704,000 | – | 851,291 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management III, LLC | 2,066,529 | $38,541,000 | 23.79% |
| Novo Holdings A/S | 2,674,470 | $49,879,000 | 8.54% |
| ACUTA CAPITAL PARTNERS, LLC | 369,500 | $6,891,000 | 4.97% |
| RTW INVESTMENTS, LP | 3,521,856 | $63,819,000 | 3.80% |
| Boxer Capital, LLC | 1,102,194 | $20,556,000 | 1.49% |
| Ghost Tree Capital, LLC | 235,000 | $4,383,000 | 1.12% |
| VHCP Management II, LLC | 148,560 | $2,771,000 | 1.06% |
| Tekla Capital Management LLC | 46,940 | $812,000 | 0.04% |
| Baker Brothers Advisors | 266,667 | $4,973,000 | 0.03% |
| Zimmer Partners, LP | 160,000 | $2,984,000 | 0.03% |